Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To determine the maximum tolerated dose (MTD) and dose-limiting toxicities (DLT) of escalating doses of imatinib in combination with hydroxyurea (HU) plus initial radiotherapy (RT) after surgery in patients with newly diagnosed glioblastoma multiforme (GBM) who are receiving or who are not receiving EIACD in phase I.
Critère d'inclusion
- Glioblastoma Multiforme